Regulation of the human leukemia inhibitory factor gene by ets transcription factors

NeuroImmunoModulation

Volumn 11, Issue 1, 2004, Pages 10-19

  Bamberger, Ana Maria ^a   Jenatschke, Susanne ^a   Schulte, Heinrich M ^a   Ellebrecht, Iring ^b   Ulrich Beil, Frank ^b   Bamberger, Christoph M ^a,b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

Author keywords

ets; Jurkat cells; Leukemia inhibitory factor

Indexed keywords

IONOMYCIN; LEUKEMIA INHIBITORY FACTOR; LUCIFERASE; PHORBOL ESTER; TRANSCRIPTION FACTOR;

ACUTE LYMPHOCYTIC LEUKEMIA; ARTICLE; BINDING SITE; CELL ACTIVATION; CONTROLLED STUDY; DNA BINDING; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LYMPHOID CELL; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WILD TYPE;

BINDING SITES; DNA; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GENETIC VECTORS; HUMANS; INTERLEUKIN-6; JURKAT CELLS; LEUKEMIA INHIBITORY FACTOR; LYMPHOCYTE ACTIVATION; MUTATION; PHORBOL ESTERS; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEIN C-ETS-1; PROTO-ONCOGENE PROTEIN C-ETS-2; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; REPRESSOR PROTEINS; RNA, MESSENGER; T-LYMPHOCYTES; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 0141957997     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000072964     Document Type: Article

References (48)

1. Gearing DP: The leukemia inhibitory factor and its receptor. Adv Immunol 1993;53:31-58.
2. Pennica D, Wood WI, Chien KR: Cardiotrophin-1: A multifunctional cytokine that signals via LIF receptor-gp 130 dependent pathways. Cytokine Growth Factor Rev 1996;7:81-91.
3. Taupin JL, Pitard V, Dechanet J, Miossec V, Gualde N, Moreau JF: Leukemia inhibitory factor: Part of a large ingathering family. Int Rev Immunol 1998,16:397-426.
4. Gearing DP, Gough NM, King JA, Hilton DJ, Nicola NA, Simpson RJ, Nice EC, Kelso A, Metcalf D: Molecular cloning and expression of cDNA encoding a murine myeloid leukemia inhibitory factor (LIF). EMBO J 1987;6:3995-4002.
5. Hilton DJ, Nicola NA, Gough NM, Metcalf D: Resolution and purification of three distinct factors produced by Krebs ascite cells which have differentiation-inducing activity on murine myeloid leukemic cell lines. J Biol Chem 1988;263:9238-9243.
6. Lotz M, Moats T, Villiger PM: Leukemia inhibitory factor is expressed in cartilage and synovium. Potential contributions to the pathogenesis of arthritis. J Clin Invest 1992;90:888-896.
7. Gadient RA, Patterson PH: Leukemia inhibitory factor. Interleukin 6, and other cytokines using the GP130 transducing receptor: Roles in inflammation and injury. Stem Cells 1999;17:127-137.
8. Baumann H, Wong GG: Hepatocyte-stimulating factor III shares structural and functional identity with leukemia-inhibitory factor. J Immunol 1989;143:1163-1167.
9. Wang Z, Ren SG, Melmed S: Hypothalamic and pituitary leukemia inhibitory factor gene expression in vivo: A novel endotoxin-inducible neuro-endocrine interface. Endocrinology 1996;137:2947-2953.
10. Auernhammer CJ, Melmed S: Leukemia-inhibitory factor-neuroimmune modulator of endocrine function. Endocr Rev 2000;21:313-345.
11. Bamberger A, Schulte HM, Wullbrand A, Jung R, Beil FU, Bamberger CM: Expression of leukemia inhibitory factor (LIF) and LIF receptor (LIF-R) in the human adrenal cortex: Implications for steroidogenesis (in process citation). Mol Cell Endocrinol 2000;162:145-149.
12. Hilton DJ, Nicola NA, Metcalf D: Distribution and comparison of receptors for leukemia inhibitory factor on murine hemopoietic and hepatic cells. J Cell Physiol 1991;146(2):207-215.
13. Bamberger A-M, Thuneke I, Schulte HM: Differential regulation of the human 'leukemia inhibitory factor' (LIF) promoter in T47D and MDA-MB 231 breast cancer cells. Breast Cancer Res Treat 1998;47:153-161.
14. Bamberger AM, Jenatschke S, Erdmann I, Schulte HM: Progestin-dependent stimulation of the human leukemia inhibitory factor promoter in SKUT-1B uterine tumor cells. J Reprod Immunol 1997;32:189-201.
15. Bamberger AM, Erdmann I, Bamberger CM, Jenatschke S, Schulte HM: Transcriptional regulation of the human 'leukemia inhibitory factor' (LIF) gene: Modulation by glucocorticoids and estradiol. Mol Cell Endocrinol 1997;127:71-79.
16. Watson DK, McWilliams MJ, Lapis P, Lautenberger JA, Schweinfest CW, Paps TS: Mammalian ets-1 and ets-2 genes encode highly conserved proteins. Proc Natl Acad Sci USA 1988; 85:7862-7866.
17. Bamberger C, Else T, Bamberger A, Beil F, Schulte H: Dissociative glucocorticoid activity of medroxyprogesterone acetate (MPA) in normal human lymphocytes. J Clin Endocrinol Metab 1999;in press.
18. Berridge MJ: Lymphocyte activation in health and disease. Crit Rev Immunol 1997;17:155-178.
19. Favero J, Lafont V: Effector pathways regulating T cell activation. Biochem Pharmacol 1998;56:1539-1547.
20. Peterson EJ, Koretzky GA: Signal transduction in T lymphocytes. Clin Exp Rheumatol 1999;17:107-114.
21. Croft M, Dubey C: Accessory molecule and costimulation requirements for CD4 T cell response. Crit Rev Immunol 1997;17:89-118.
22. Ward SG: CD28: A signalling perspective. Biochem J 1996;318:361-377.
23. 2+ ionophore in activation of protein kinase C (PKC) alpha and PKC beta isoenzymes in human T cells and in induction of related cellular functions. Immunology 1992;76:465-471.
24. Arai N, Naito Y, Watanabe M, Masuda ES, Yamaguchi-Iwai Y, Tsuboi A, Heike T, Matsuda I, Yokota K, Koyano-Nakagawa N, et al: Activation of lymphokine genes in T cells: Role of cis-acting DNA elements that respond to T cell activation signals. Pharmacol Ther 1992;55:303-318.
25. Rothenberg EV, Ward SB: A dynamic assembly of diverse transcription factors integrates activation and cell-type information for interleukin-2 gene regulation. Proc Natl Acad Sci USA 1996;93:9358-9365.
26. Hughes CCW, Pober JS: Transcriptional regulation of the interleukin-2 gene in normal human peripheral blood T cells. J Biol Chem 1996;271:5369-5377.
27. Bamberger CM, Else T, Bamberger AM, Beil FU, Schulte HM: Regulation of the human interleukin-2 gene by the alpha and beta isoforms of the glucocorticoid receptor. Mol Cell Endocrinol 1997;136:23-28.
28. Vacca A, Felli MP, Farina AR, Martinotti S, Maroder M, Screpanti I, Meco D, Petrangeli E, Frati L, Gulino A: Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP-1 enhancer elements. J Exp Med 1992;175:637-646.
29. Paliogianni F, Raptis A, Ahuja SS, Najjar SM, Boumpas DT: Negative transcriptional regulation of human interleukin 2 (IL-2) gene by glucocorticoids through interference with nuclear transcription factors AP-1 and NF-AT. J Clin Invest 1993;91:1481-1489.
30. Northrop JP, Crabtree GR, Mattila PS: Negative regulation of interleukin 2 transcription by the glucocorticoid receptor. J Exp Med 1992;175:1235-1245.
31. Bassuk A, Anandappa R, Leiden J: Physical interactions between Ets and NF-kappaB/NFAT proteins play an important role in their cooperative activation of the human immunodeficiency virus enhancer in T cells. J Virol 1997;71:3563-3573.
32. Sharrocks AD, Brown AL, Ling Y, Yates PR: The ETS-domain transcription factor family. Int J Biochem Cell Biol 1997;29:1371-1387.
33. Macleod K, Leprince D, Stehelin D: The ets gene family. Trends Biochem Sci 1992;17:251-256.
34. Dittmer J, Nordheim A: Ets transcription factors and human disease. Biochim Biophys Acta 1998;1377:F1-11.
35. Galanis A, Yang SH, Sharrocks AD: Selective targeting of MAPKs to the ETS domain transcription factor SAP-1. J Biol Chem 2001;276:965-973.
36. Crepieux P, Coll J, Stehelin D: The Ets family of proteins: Weak modulators of gene expression in quest for transcriptional partners. Crit Rev Oncog 1994;5:615-638.
37. Boehlk S, Fessele S, Mojaat A, Miyamoto NG, Werner T, Nelson EL, Schlondorff D, Nelson PJ: ATF and Jun transcription factors, acting through an Ets/CRE promoter module, mediate lipopolysaccharide inducibility of the chemokine RANTES in monocytic Mono Mac 6 cells. Eur J Immunol 2000;30:1102-1112.
38. Bidder M, Loewy AP, Latifi T, Newberry EP, Ferguson G, Willis DM, Towler DA: Ets domain transcription factor PE1 suppresses human interstitial collagenase promoter activity by antagonizing protein-DNA interactions at a critical AP1 element. Biochemistry 2000;39:8917-8928.
39. Tymms MJ, Kola I: Regulation of gene expression by transcription factors Ets-1 and Ets-2. Mol Reprod Dev 1994;39:208-214.
40. Bassuk AG, Leiden JM: The role of Ets transcription factors in the development and function of the mammalian immune system. Adv Immunol 1997;64:65-104.
41. Tsai EY, Falvo JV, Tsytsykova AV, Barczak AK, Reimold AM, Glimcher LH, Fenton MJ, Gordon DC, Dunn IF, Goldfeld AE: A lipopolysaccharide-specific enhancer complex involving Ets, Elk-1, Sp1, and CREB binding protein and p300 is recruited to the tumor necrosis factor alpha promoter in vivo. Mol Cell Biol 2000;20:6084-6094.
42. Kramer B, Wiegmann K, Kronke M: Regulation of the human TNF promoter by the transcription factor Ets. J Biol Chem 1995;270:6577-6583.
43. Ma X, Neurath M, Gri G, Trinchieri G: Identification and characterization of a novel Ets-2-related nuclear complex implicated in the activation of the human interleukin-12 p40 gene promoter. J Biol Chem 1997;272:10389-10395.
44. Rosen GD, Barks JL, Iademarco MF, Fisher RJ, Dean DC: An intricate arrangement of binding sites for the Ets family of transcription factors regulates activity of the alpha 4 integrin gene promoter. J Biol Chem 1994;269:15652-15660.
45. De Launoit Y, Audette M, Pelczar H, Plaza S, Baert JL: The transcription of the intercellular adhesion molecule-1 is regulated by Ets transcription factors. Oncogene 1998;16:2065-2073.
46. Thomas RS, Tymms MJ, Seth A, Shannon MF, Kola I: ETS1 transactivates the human GM-CSF promoter in Jurkat T cells stimulated with PMA and ionomycin. Oncogene 1995;11:2135-2143.
47. Dooley S, Herlitzka I, Hanselmann R, Ermis A, Henn W, Remberger K, Hopf T, Welter C: Constitutive expression of c-fos and c-jun, overexpression of ets-2, and reduced expression of metastasis suppressor gene nm23-H1 in rheumatoid arthritis. Ann Rheum Dis 1996;55:298-304.
48. Bell MC, Carroll GJ: Rheumatoid synovial fluid contains bioactive leukemia inhibitory factor with cartilage degrading activity: Another target for chondroprotective intervention. J Rheumatol 2000;27:332-338.